# Clinical Utility of Electrical Impedance Spectroscopy

> **NCT04161742** · NA · UNKNOWN · sponsor: **SciBase AB** · enrollment: 180 (estimated)

## Conditions studied

- Focus of Study: Patients With Suspicion of Melanoma

## Interventions

- **DEVICE:** Nevisense

## Key facts

- **NCT ID:** NCT04161742
- **Lead sponsor:** SciBase AB
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12
- **Primary completion:** 2020-06
- **Final completion:** 2020-08
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2019-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04161742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04161742, "Clinical Utility of Electrical Impedance Spectroscopy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04161742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*